12.85
0.31%
-0.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RCEL Giù?
Forum
Previsione
Frazionamento azionario
Avita Medical Inc Azioni (RCEL) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
21.78%
11.10
|
14.20 | 13.64 | 11.75 | 10.55 |
Cost Of Revenue |
15.76%
1.513
|
1.796 | 2.113 | 2.204 | 1.667 |
Gross Profit |
22.65%
9.591
|
12.40 | 11.53 | 9.549 | 8.883 |
Operating Expenses
|
8.35%
26.80
|
24.73 | 21.05 | 21.24 | 19.42 |
Interest Income/Expense |
20.86%
1.356
|
1.122 | 0.01 | 0.007 | 0.004 |
Benefits Costs and Expenses |
39.93%
29.73
|
21.25 | 22.35 | 22.12 | 19.74 |
Costs And Expenses |
39.93%
29.73
|
21.25 | 22.35 | 22.12 | 19.74 |
Provision For Loan, Lease, And Other Losses |
189.89%
0.08
|
-0.089 | -0.089 | 0.03 | 0.172 |
Operating Income/Loss |
40.19%
-17.21
|
-12.27 | -9.306 | -11.16 | -9.911 |
Income/Loss From Continuing Operations Before Tax |
164.11%
-18.63
|
-7.053 | -8.701 | -10.37 | -9.19 |
Income Tax Expense/Benefit |
150.00%
0.03
|
0.012 | 0.011 | 0.013 | 0.03 |
Income/Loss From Continuing Operations After Tax |
164.09%
-18.66
|
-7.065 | -8.712 | -10.38 | -9.22 |
Net Income/Loss
|
164.09%
-18.66
|
-7.065 | -8.712 | -10.38 | -9.22 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
51,857%
25.64
|
0.0493 | 25.40 | 25.24 | 25.20 |
Diluted Average Shares |
51,857%
25.64
|
0.0493 | 25.40 | 25.24 | 25.20 |
Basic Earnings Per Share |
360.71%
-0.73
|
0.28 | 0.34 | 0.41 | 0.37 |
Diluted Earnings Per Share |
360.71%
-0.73
|
0.28 | 0.34 | 0.41 | 0.37 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):